21 May 2013
17 February 1992
The proliferation of flu remedies currently appearing on US drugstore shelves is more a product of marketing than medical breakthroughs,...
17 February 1992
The US market for generic drugs will more than double from a value of $5.5 billion in 1991 to reach...
17 February 1992
Genzyme Corp has announced that its researchers have developed the first genetically-engineered mice to produce in their milk a membrane...
17 February 1992
Norwegian company Haflsund Nycomed reported a massive 46% rise in total operating profits for 1991, reaching 1.58 billion Norwegian kroner...
17 February 1992
The value of over-the-counter medicine franchises will continue to rise and as a result smaller OTC drugmakers (such as Carter...
10 February 1992
Morocco is the latest country to ban marketing of Roussel Uclaf's glafenine-based analgesic products Adalgur, Glifanan and Myantal. A...
10 February 1992
The possibility that histamine H2 receptor blockers may be useful as a treatment for individuals with rhinitis has been raised...
10 February 1992
Klaus Stuerzbecher, president of the German federation of pharmacists, the ABDA, has said that a new ABDA study shows that,...
10 February 1992
The US Food and Drug Administra-tion's Oncologic Drugs Advisory Committee has declined to recommend marketing approval of US Biosci-ence Inc's...
10 February 1992
Two US biotechnology companies have agreed to develop potential treatments for stroke and other acute degenerative brain disorders. Cortex Pharmaceuticals...